about
Estimation of Cancer Burden Attributable to Infection in AsiaPooled analysis on the necessity of random 4-quadrant cervical biopsies and endocervical curettage in women with positive screening but negative colposcopyHigh-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.Analysis of the effectiveness of visual inspection with acetic acid/Lugol's iodine in one-time and annual follow-up screening in rural China.Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trial.Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trialEffect of an educational intervention on HPV knowledge and vaccine attitudes among urban employed women and female undergraduate students in China: a cross-sectional study.Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in ChinaEstimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China.Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studiesPrevalence of HPV Infection And Cervical Intraepithelial Neoplasia And Attitudes towards HPV Vaccination among Chinese Women Aged 18-25 in Jiangsu Province.How university students view human papillomavirus (HPV) vaccination: A cross-sectional study in Jinan, China.Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in ChinaAssessment of quality of life for the patients with cervical cancer at different clinical stages.Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized controlled trial.Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis.Role of active and passive smoking in high-risk human papillomavirus infection and cervical intraepithelial neoplasia grade 2 or worse.Perceptions and acceptability of HPV vaccination among parents of young adolescents: a multicenter national survey in China.Management algorithms for cervical cancer screening and precancer treatment for resource-limited settings.Prospective comparison of hybrid capture 2 and SPF₁₀-LiPA for carcinogenic human papillomavirus detection and risk prediction of cervical cancer: a population-based cohort study in China.Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in China.[Prevalence of human papillomavirus infection and risk of cervical cancer or precancerous lesions in 15 years follow up: a prospective cohort study].Knowledge of human papillomavirus vaccination and related factors among parents of young adolescents: a nationwide survey in China.Clinical determinants of a positive visual inspection after treatment with acetic acid for cervical cancer screening.A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.[Trend analysis of cervical cancer incidence and mortality rates in Chinese women during 1989-2008].Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology.[Effectiveness and health economic analysis of strategies on cervical cancer screening and early diagnosis and treatment].Comprehensive cervical cancer prevention and control in the Asia Pacific region: the 6th Biennial Conference of the Asia Oceania Research Organization on Genital Infections & Neoplasia (AOGIN).The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management.Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China.Risk of high-risk human papillomavirus infection and cervical precancerous lesions with past or current trichomonas infection: a pooled analysis of 25,054 women in rural China.Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in ChinaClinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA orTraining Future Leaders: Experience from China-ASEAN Cancer Control Training ProgramComparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in ChinaPrevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategiesThe association between dietary intake and cervical intraepithelial neoplasia grade 2 or higher among women in a high-risk rural area of chinaRisk factors for HPV infection and cervical cancer among unscreened women in a high-risk rural area of China[Research progression of prophylactic HPV vaccine application]
P50
Q26781786-4C77CC4A-E234-4A16-936A-126432CACF5EQ33627102-24C72F5F-8002-496F-BB5A-B92E8D431033Q33735091-92EE4C0E-295A-480A-9410-8982F56DD211Q33777077-40C4285E-D527-46EB-9552-23BC74214C9DQ34776171-08806832-6E31-40D4-88BC-F4649C833FD5Q34776205-F68BC1A6-ADE5-4410-B225-EE81A6566F29Q35006857-EC68EACE-9E80-4CC3-B2CD-DACF97A333E8Q35937679-B43A1FC7-D826-42EA-A354-3862DD35C258Q36183172-1C772AFC-09CF-4A32-B132-7A37FF3F89BEQ36213568-27EBE05E-E684-4B6C-A2E0-05702900E36EQ36654583-8812D1C7-775D-4077-BCF0-D4D25542B85DQ37130154-30822FF4-F7C0-4BA9-A903-4F2DAA60ACE6Q37179540-B64EC31C-5675-4545-8360-359B18EFDCE2Q37353965-E7A88F5A-6600-40ED-87DA-DE87F65EA4F1Q37609451-7AE852DB-E85D-4431-A6CB-60388A3AE82AQ38179114-84C0B2CF-6EB3-4751-B866-902DB76EE3C5Q38705382-EFA6696F-1AC1-4D7A-B435-9CFF606C47C3Q39412809-A51C2CA1-154C-4391-A9B9-3DE677DBB090Q40129828-E19CB67D-096E-4CDA-88CF-EAD18FE0CF9EQ40142951-E4421DEC-DA90-4467-9E59-190C5E7A51F6Q40179565-B5C9B49C-C705-4952-ACAE-87D1D1A7F608Q40483054-D359D320-1467-4B6B-89AA-21D3C28E92E4Q41471457-12FEF37C-C611-4032-9E7A-0F701596540CQ42234874-801875C8-5A27-4D0C-9C4A-75C94300BEC3Q44511961-9DBAE748-8E0C-48F2-981D-F95347CDBC3AQ44563747-74B168D0-815C-40B5-8CD5-2F040C626D7DQ44658549-5492431C-9EAB-4916-83B3-F3EE27E4B7F0Q44673096-00D21B41-2A22-4AC1-AB63-E0144F0F9EC1Q45853638-8D3ED834-F0C0-4674-8D65-77D6C05D85B4Q46313049-38B16558-6B79-4878-AE77-C3C8091797A2Q47239245-4CD59963-588F-4A30-8302-90BC261A039AQ49359113-D5882E12-A789-42DB-96BD-2FFF3AC1A08BQ57068196-96483AC7-EC75-4EA2-921E-7E49D9D7CBE8Q57121573-0FD4CE33-F040-4F43-AA7A-85E3E0A6DE4BQ57169844-F127AB46-74B7-44DC-A17A-254562397522Q58299110-8FACFDC3-5491-46C9-A20A-516B1971DE37Q58299168-F3BF7F63-9EB2-4A39-833E-DCE7BE5CBEBCQ58299201-7ABEBDBB-33EF-482D-8FE9-B4A4D00DC520Q58299621-D40AEAFC-EB20-434B-9658-E6B361AC516DQ58578204-A98FD7DF-F4AF-46FB-941B-AEC3F3F26134
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
F H Zhao
@en
F H Zhao
@nl
type
label
F H Zhao
@en
F H Zhao
@nl
prefLabel
F H Zhao
@en
F H Zhao
@nl
P31
P496
0000-0001-9294-0005